CJC-1295 + GHRP-2 (10mg Vial) Dosage Protocol
Quickstart Highlights
CJC-1295 + GHRP-2 (10mg) dosage protocol is commonly used to support growth hormone (GH) release, with research suggesting potential benefits in body composition and recovery. This blend typically splits the vial into ~5mg of CJC-1295 and ~5mg of GHRP-2.
- Often administered 1–2 times per day, 5 days per week
- Can be reconstituted with up to 3 mL for more accurate dosing
- Avoid extremely low “units” by using larger dilution volumes or smaller syringes
- Store lyophilized in the freezer and reconstituted in the refrigerator
- Protocol durations generally range 8–16 weeks
Dosing & Reconstitution Guide
Educational guide for reconstitution and dosing protocol
Standard / Gradual Approach (3 mL Reconstitution)
| Weeks | Dose per Injection (mcg) | Units (per injection) | Frequency |
|---|---|---|---|
| 1–4 | 300 mcg total (≈150 mcg each peptide) | ~9 units | 2x daily, 5 days/week |
| 5–8 | 400 mcg total (≈200 mcg each peptide) | ~12 units | 2x daily, 5 days/week |
Reconstituting with 3 mL keeps injection volume manageable. If doses under ~10 units are needed, consider using 50-unit or 30-unit insulin syringes for better precision.
- Draw 3.0 mL of bacteriostatic water into a sterile syringe.
- Inject slowly along the vial wall to minimize foaming.
- Gently swirl—avoid vigorous shaking.
- Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Advanced / Aggressive Approach (2 mL Reconstitution)
| Weeks | Dose per Injection (mcg) | Units (per injection) | Frequency |
|---|---|---|---|
| 1–4 | 500 mcg total (≈250 mcg each peptide) | 10 units | 2x daily, 5 days/week |
| 5–8 | 600 mcg total (≈300 mcg each peptide) | 12 units | 2x daily, 5 days/week |
| 9–12 (Optional) | 800 mcg total (≈400 mcg each peptide) | 16 units | 2x daily, 5 days/week |
For those seeking more pronounced effects, reconstitute with 2 mL (5 mg/mL). Each unit on a 100-unit syringe will deliver ~50 mcg of the total blend.
- Draw 2.0 mL of bacteriostatic water into a sterile syringe.
- Slowly inject along the vial interior to prevent foam.
- Gently roll/swirl—no vigorous shaking.
- Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Protocol Overview
A concise summary of CJC-1295 + GHRP-2 daily-injection strategies.
- Goal: Enhance GH release to support muscle maintenance and recovery
- Schedule: Typically 2 injections per day, 5 days on / 2 days off
- Dose Range: 300–800 mcg total per injection, depending on tolerance
- Reconstitution: Up to 3 mL to maintain measurable dosing units
- Storage: Freeze lyophilized; refrigerate (2–8°C) once mixed
Dosing Protocol
Split daily doses to align with natural GH pulses. An empty stomach (2–3 hours post-meal) is recommended.
- Frequency: 1–2 injections per day (morning and/or before bedtime)
- Cycle Length: 8–16 weeks, with possible breaks after completion
- Weekly Schedule: 5 days on, 2 days off for recovery
- Injection Sites: Subcutaneous (abdomen, thigh, or upper arm)
- Adjustments: Increase gradually to manage any side effects
Storage Instructions
Proper storage preserves the peptide’s potency and integrity.
- Lyophilized: Store in freezer (−20°C) until ready to mix
- Reconstituted: Keep refrigerated at 2–8°C
- Use within 30 days of mixing
- Minimize temperature fluctuations and avoid freeze-thaw cycles
Supplies Needed
Gather these materials for an 8–16 week peptide cycle.
- Peptide Vials:
• 8 wks ≈ 2 vials
• 12 wks ≈ 3 vials
• 16 wks ≈ 4 vials
(Higher doses or longer cycles may require more) - Insulin Syringes:
• 8 wks ≈ 10–16
• 12 wks ≈ 20+
• 16 wks ≈ 30+
(Consider 50-unit or 30-unit syringes if dosing below ~10 units) - Bacteriostatic Water: 1× 30ml (or more as needed)
- Alcohol Swabs: 1 box
Important Notes
Practical tips to enhance safety and efficacy.
- Always use new, sterile insulin syringes & rotate injection sites.
- Take doses on an empty stomach (2–3 hours after your last meal).
- Monitor for side effects and discontinue if adverse reactions occur.
- Document progress weekly; adjust dosage only if advised by a professional.
How This Works
CJC-1295 and GHRP-2 act on separate pathways to amplify growth hormone (GH) release.
- CJC-1295: A growth hormone-releasing hormone (GHRH) analog that promotes sustained GH release
- GHRP-2: A ghrelin mimetic that triggers additional GH secretion via the GHS-R pathway
- Combined use may enhance GH pulsatility, supporting muscle repair and metabolism
Potential Benefits & Side Effects
Users often report improved recovery and body composition, though experiences vary.
- May help maintain lean muscle and improve workout recovery
- Potential mild side effects include headache, flushing, or injection-site irritation
- Some individuals note increased appetite (common with GHRP peptides)
- Any severe or persistent side effects warrant professional evaluation
Lifestyle Factors
Complement the protocol with these healthy habits.
- Maintain a balanced diet with sufficient protein
- Regular resistance training and cardiovascular exercise
- Prioritize adequate sleep and stress management
Injection Technique
Simple guidelines for safe daily injections.
- Clean vial rubber stopper & injection site with alcohol swabs
- Insert needle at a 45–90° angle into subcutaneous tissue
- Inject slowly & rotate sites (abdomen, thigh, etc.)
Recommended Source
We recommend Pure Lab Peptides for high-purity CJC-1295 + GHRP-2 blend.
Why Pure Lab Peptides?
- Verifies ≥99% purity through independent lab testing
- Trusted by researchers seeking reliable results
- Follows rigorous manufacturing standards for consistent quality
Important Note
This guide is for educational purposes only. Always consult a qualified healthcare provider before starting or modifying any therapy.
References
-
PubMed
– GH release findings in human subjects -
FDA Document
– Regulatory guidance on GH peptides -
AJP Endocrinology
– Investigates GH and IGF-1 regulation -
Asian-Australasian J Anim Sci
– Animal model research on GH peptides -
Wiley Online Library
– Study examining metabolic hormone interactions -
Medsafe.govt.nz
– Government review on performance enhancers -
Sciensano
– Belgian research exploring endocrine pathways